Literature DB >> 6189542

The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine.

M K Church, K D Young.   

Abstract

1 Three drugs have been tested for activity against antigen-induced histamine release from passively sensitized human lung fragments after increasing periods of pre-incubation before challenge.2 After 30 s pre-incubation, sodium cromoglycate inhibited histamine release in the concentration range 0.2-200 muM, producing a maximum inhibition of 33.0%. As the pretreatment period was extended, tolerance developed in a dose-related manner, resulting in a 48.3% and 82.8% loss of activity of the 200 muM dose after 60 min and 19 h pre-incubation, respectively. Tolerance was independent of extracellular calcium and was poorly reversible. Lung tissue desensitized to cromoglycate was cross-tolerant to the related drug, bufrolin, but not to salbutamol or chlorpromazine.3 In acute studies, salbutamol (0.03-3.0 muM) produced dose-related inhibition of histamine release, with a maximum inhibition of 72.2%. The effect was blocked stereoselectively by 1 muM propranolol, suggesting that it occurred through an interaction with lung beta-adrenoceptors. Increasing the pre-incubation time with salbutamol from 30 s to 19 h did not produce tolerance. Inhibition produced by incubation with salbutamol for 19 h was totally prevented when propranolol was added at the beginning of the pre-incubation period, indicating that it resulted from stimulation of beta-receptors and not from a non-specific or toxic effect. However, studies of reversibility of effect through washing or late addition of propranolol did indicate some change in the nature of salbutamol inhibition with time.4 Chlorpromazine was a weak inhibitor of immunological histamine release. A 100 muM concentration was ineffective after 30 s pre-incubation but its activity increased with time. Pre-incubation of lung fragments with this concentration for 1 h or longer, or with a 1 mM dose for a shorter period, provoked histamine release in the absence of antigen. Effects of chlorpromazine were not reversed by washing.5 The different characteristics shown by sodium cromoglycate, salbutamol and chlorpromazine indicate that these drugs inhibit histamine release by interfering with the secretory mechanisms in different ways.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189542      PMCID: PMC2044757          DOI: 10.1111/j.1476-5381.1983.tb09419.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Drug-induced changes in the release and uptake of biogenic amines. A study on mast cells.

Authors:  M Frisk-Holmberg
Journal:  Acta Physiol Scand Suppl       Date:  1972

2.  Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung.

Authors:  P Sheard; A M Blair
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

3.  Inhibition of histamine release from human lung in vitro by antihistamines and related drugs.

Authors:  M K Church; C F Gradidge
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

Review 4.  The Robert A. Cooke memorial lecture. Analysis of triggering events in mast cells for immunoglobulin E-mediated histamine release.

Authors:  T Ishizaka
Journal:  J Allergy Clin Immunol       Date:  1981-02       Impact factor: 10.793

5.  The binding of chlorpromazine to some fractions of homogenized rat brain.

Authors:  A Rosen; S Y Tham
Journal:  J Pharm Pharmacol       Date:  1980-05       Impact factor: 3.765

6.  Bronchodilator drugs.

Authors:  J W Paterson; A J Woolcock; G M Shenfield
Journal:  Am Rev Respir Dis       Date:  1979-11

7.  Further studies on the tachyphylaxis to DSCG. The effects of concentration and temperature.

Authors:  C P Sung; H L Saunders; E Lenhardt; L W Chakrin
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

8.  beta-adrenergic agonist resistance in normal human airways.

Authors:  S T Holgate; C J Baldwin; A E Tattersfield
Journal:  Lancet       Date:  1977-08-20       Impact factor: 79.321

9.  Inhibition of the release of histamine from rat mast cells: the effect of cold and adrenergic drugs on release of histamine by compound 48-80 and antigen.

Authors:  A R Johnson; N C Moran
Journal:  J Pharmacol Exp Ther       Date:  1970-12       Impact factor: 4.030

10.  Effect of terbutaline on cutaneous responses in man to rechallenge with allergen and compound 48/80.

Authors:  R Grönneberg; K Strandberg
Journal:  Allergy       Date:  1981-01       Impact factor: 13.146

View more
  11 in total

Review 1.  Staub and Bovet Award 1989 lecture. Some aspects of mast cell subtypes from human lung tissue.

Authors:  F J van Overveld
Journal:  Agents Actions       Date:  1990-04

2.  Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells.

Authors:  K B Leung; K C Flint; J Brostoff; B N Hudspith; N M Johnson; H Y Lau; W L Liu; F L Pearce
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

3.  Inhibition of histamine release from dispersed human lung and tonsillar mast cells by nicardipine and nifedipine.

Authors:  Y Y Kim; S T Holgate; M K Church
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

4.  Bronchorelaxation and plasma histamine after salbutamol inhalation.

Authors:  I Macquin; A Harf; F Zerah; C Sabatier; F Lhoste
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

6.  Nedocromil sodium inhibits antigen-induced contraction of human lung parenchymal and bronchial strips, and the release of sulphidopeptide-leukotriene and histamine from human lung fragments.

Authors:  F E Napier; M A Shearer; D M Temple
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

7.  Importance of beta 2-adrenoceptor stimulation in the suppression of intradermal antigen challenge by adrenaline.

Authors:  J B Warren; F J Pixley; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

8.  The effects of cremophor EL in the anaesthetized dog.

Authors:  J H Gaudy; J F Sicard; F Lhoste; J F Boitier
Journal:  Can J Anaesth       Date:  1987-03       Impact factor: 5.063

Review 9.  Pharmacology of airway inflammation in asthma.

Authors:  K F Chung
Journal:  Lung       Date:  1990       Impact factor: 2.584

10.  Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.

Authors:  M K Church; J Hiroi
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.